- Home
- KYMR vs PHI Comparison
KYMR vs PHI Comparison
Compare KYMR & PHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- PHI
- Stock Information
- Founded
- KYMR 2015
- PHI 1928
- Country
- KYMR United States
- PHI Philippines
- Employees
- KYMR N/A
- PHI N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- PHI Telecommunications Equipment
- Sector
- KYMR Health Care
- PHI Telecommunications
- Exchange
- KYMR Nasdaq
- PHI Nasdaq
- Market Cap
- KYMR 4.3B
- PHI 4.1B
- IPO Year
- KYMR 2020
- PHI 1953
- Fundamental
- Price
- KYMR $59.70
- PHI $18.92
- Analyst Decision
- KYMR Strong Buy
- PHI Hold
- Analyst Count
- KYMR 17
- PHI 1
- Target Price
- KYMR $63.76
- PHI N/A
- AVG Volume (30 Days)
- KYMR 771.9K
- PHI 118.4K
- Earning Date
- KYMR 10-30-2025
- PHI 11-11-2025
- Dividend Yield
- KYMR N/A
- PHI 6.37%
- EPS Growth
- KYMR N/A
- PHI 20.57
- EPS
- KYMR N/A
- PHI 2.62
- Revenue
- KYMR $44,711,000.00
- PHI $3,879,170,293.00
- Revenue This Year
- KYMR $62.11
- PHI $3.27
- Revenue Next Year
- KYMR N/A
- PHI $3.07
- P/E Ratio
- KYMR N/A
- PHI $7.14
- Revenue Growth
- KYMR N/A
- PHI 2.02
- 52 Week Low
- KYMR $19.45
- PHI $18.61
- 52 Week High
- KYMR $63.96
- PHI $26.38
- Technical
- Relative Strength Index (RSI)
- KYMR 62.28
- PHI 39.40
- Support Level
- KYMR $58.00
- PHI $18.66
- Resistance Level
- KYMR $63.96
- PHI $19.12
- Average True Range (ATR)
- KYMR 2.65
- PHI 0.28
- MACD
- KYMR 0.00
- PHI 0.11
- Stochastic Oscillator
- KYMR 56.84
- PHI 49.21
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About PHI PLDT Inc. Sponsored ADR
PLDT Inc is the telecommunications carrier in the Philippines. The company's business activities include three business units: Wireless, Fixed Line and Others. The wireless segment consists of mobile telecommunications services provided by Smart and DMPI, and Fixed-line telecommunications services mainly provided by PLDT. It also provides fixed-line services through PLDT's subsidiaries.